Visiting from the US? Discover Helixafe, our Cancer Driver Interception program →
What we do
About Bioscience
Professionals
Science & innovation News & media Shop NowTalk to an expert
Italianoالعربية中文

Cancer driver interception

Monitoring of genome instability

HELIXBALANCE

Monitoring of genome instability

HELIXBALANCE identifies genome instability by monitoring somatic mutations and therefore the tumor suppressor genes that are responsible for their formation.

Why perform HELIXBALANCE test

Genome instability occurs when, due to some mutations at the level of tumor suppressor genes, somatic mutations accumulate; this condition is symptomatic of the body’s inability to repair DNA.

Thanks to the HELIXBALANCE test, it is possible to monitor mutations and identify genome instability in order to manage it by acting on lifestyle and optimizing the intake of nutrients (vitamins).

Table 28genes helixbalance

What the test evaluates?

The non-invasive HELIXBALANCE analysis can identify and monitor some mutations responsible for the genome instability caused by the accumulation of genetic and epigenetic alterations that occur during the life of a healthy individual, over a variable period of time.

How the test is performed

The test involves a simple blood sample that can be performed at one of our reference centers or through your trusted doctor.
The Bioscience Institute laboratories extract the DNA present in the sample and sequence it using advanced Next Generation Sequencing (NGS) techniques. The subsequent bioinformatic analysis allows to determine the presence of any mutations in the genes under examination.
Test results are available in approximately 30 days.

Procedure helixbalance en

Request HELIXBALANCE

Request the HELIXBALANCE test to know your level of genome instability.

Call  +971 (0)4 375 7220, or fill out the form below to be contacted by one of our experts.

(*) required information

Scientific content reviewed by the Bioscience Institute Scientific Board. · Last updated

The information on this page is for general education and does not replace a consultation with a physician.

This page in other languages: Italiano

Cancer driver interception

Request information

Tell us your situation and a specialist from this area will get back to you, in your country and your language.

HELIXAFE reads biological drivers over time; it is not a diagnostic test and does not replace the screening programmes recommended for your age.

Cancer driver interception

Periodic monitoring of the four biological drivers that precede cancer, through five laboratory protocols.

Periodic monitoring of the four biological drivers that precede cancer: genomic instability, microbiome dysbiosis, chronic inflammation and immune dysfunction. A patented method, published in Cell Death & Disease.

Connect with us on social

Helixafe · US